Login / Signup

Choosing the right biologic for complications of inflammatory bowel disease.

Shana RakowskyKonstantinos PapamichaelAdam S Cheifetz
Published in: Expert review of gastroenterology & hepatology (2022)
There are still significant gaps in our understanding of the pathophysiology of IBD and its treatment, especially in regards to complications of the disease. As novel therapies continue to emerge for treatment of IBD, we feel concurrent examination of their impact on intestinal complications and EIM of IBD is important and should be a priority of future research.
Keyphrases
  • risk factors
  • rheumatoid arthritis
  • ulcerative colitis
  • squamous cell carcinoma
  • locally advanced